The 2022 Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings guideline by the Endocrine Society recommends the use of rt-CGM in conjunction with confirmatory bedside POC-BG testing in insulin-treated diabetes patients admitted with noncritical illness [21]. The gene discussed is INS; the disease is Hyperglycemia.